Our partnership is an investment

Founded in 2008, Eris Enterprises began as a holding company investing in innovative pharmaceutical ventures and has since evolved into an experienced player in the global pharmaceutical industry. The company has successfully completed numerous investments and mergers, acquiring substantial expertise in the sector.

Today, Eris Enterprises focuses on pioneering R&D projects, particularly in developing advanced pharmaceutical dosage forms such as immediate release, modified release, orally disintegrating tablets, and innovative formats like strips.

Leveraging its extensive experience, Eris Enterprises has built strategic partnerships in over 60 countries across Australia, Asia, Europe, the Middle East, and North Africa. The company continues to invest in cutting-edge research, partnerships, and business development, delivering high-quality, specialized pharmaceuticals tailored to diverse healthcare needs.